Activated	O
platelets	B-Cell
enhance	O
ovarian	B-Cell
cancer	I-Cell
cell	I-Cell
invasion	O
in	O
a	O
cellular	B-Cell
model	O
of	O
metastasis	O
.	O

Increased	O
platelet	B-Cell
counts	O
and	O
systemic	O
coagulation	O
activation	O
are	O
associated	O
with	O
ovarian	B-Cancer
cancer	I-Cancer
progression	O
.	O

Platelet	B-Cell
activation	O
occurs	O
in	O
the	O
tumor	B-Cancer
microenvironment	O
and	O
may	O
influence	O
local	O
invasion	O
and	O
metastasis	O
.	O

We	O
used	O
a	O
cellular	B-Cell
model	O
of	O
tumor	B-Cancer
invasion	O
to	O
investigate	O
the	O
effect	O
of	O
activated	O
platelets	B-Cell
on	O
the	O
human	O
ovarian	B-Cell
cancer	I-Cell
cell	I-Cell
line	I-Cell
,	O
SKOV3	B-Cell
.	O

SKOV3	B-Cell
cells	I-Cell
were	O
exposed	O
to	O
washed	O
,	O
thrombin	O
receptor	O
activating	O
peptide	O
(	O
TRAP	O
)	O
-	O
activated	O
or	O
TRAP	O
-	O
naive	O
platelets	B-Cell
under	O
various	O
experimental	O
conditions	O
,	O
and	O
tumor	B-Cell
cell	I-Cell
invasion	O
was	O
assayed	O
in	O
Matrigel	O
chambers	O
.	O

The	O
effect	O
of	O
platelets	B-Cell
on	O
the	O
content	O
of	O
urokinase	O
plasminogen	O
activator	O
(	O
uPA	O
)	O
and	O
VEGF	O
in	O
SKOV3	B-Cell
cell	I-Cell
conditioned	O
medium	O
was	O
measured	O
using	O
an	O
ELISA	O
assay	O
.	O

TRAP	O
-	O
activated	O
platelets	B-Cell
stimulated	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
SKOV3	B-Cell
cell	I-Cell
invasion	O
.	O

Exposure	O
to	O
activated	O
platelet	B-Cellular_component
membranes	I-Cellular_component
and	O
to	O
soluble	O
proteins	O
contained	O
in	O
activated	O
platelet	B-Cell
releasate	O
both	O
contributed	O
to	O
the	O
observed	O
increase	O
in	O
invasion	O
.	O

The	O
inhibition	O
of	O
platelet	B-Cell
activation	O
with	O
prostaglandin	O
E1	O
(	O
PGE	O
(	O
1	O
)	O
)	O
attenuated	O
the	O
invasive	O
capacity	O
of	O
SKOV3	B-Cell
cells	I-Cell
.	O

Exposure	O
to	O
platelets	B-Cell
resulted	O
in	O
significantly	O
increased	O
uPA	O
and	O
VEGF	O
content	O
of	O
SKOV3	B-Cell
cell	I-Cell
conditioned	O
medium	O
.	O

Activated	O
platelets	B-Cell
enhance	O
SKOV3	B-Cell
human	O
ovarian	B-Cell
cancer	I-Cell
cell	I-Cell
invasion	O
through	O
Matrigel	O
and	O
increase	O
the	O
amount	O
of	O
uPA	O
and	O
VEGF	O
secreted	O
into	O
SKOV3	B-Cell
cell	I-Cell
conditioned	O
medium	O
.	O

If	O
generalizable	O
to	O
additional	O
cell	B-Cell
lines	I-Cell
and	O
human	O
disease	O
,	O
this	O
observation	O
may	O
partially	O
explain	O
the	O
adverse	O
prognosis	O
associated	O
with	O
thrombocytosis	O
in	O
ovarian	B-Cancer
cancer	I-Cancer
.	O

Platelets	B-Cell
,	O
therefore	O
,	O
may	O
represent	O
a	O
potential	O
target	O
for	O
therapeutic	O
intervention	O
in	O
human	O
ovarian	B-Cancer
cancer	I-Cancer
.	O

